EP3266445 - SUSPENSION OR COMPOSITION CONTAINING NANO-COCRYSTAL AND MANUFACTURING METHOD THEREFOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.03.2023 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 08.04.2022 | ||
Former | Grant of patent is intended Status updated on 24.03.2022 | ||
Former | Examination is in progress Status updated on 18.02.2022 | ||
Former | Grant of patent is intended Status updated on 05.10.2021 | ||
Former | Examination is in progress Status updated on 24.02.2020 | ||
Former | Request for examination was made Status updated on 08.12.2017 | ||
Former | The international publication has been made Status updated on 01.09.2017 | Most recent event Tooltip | 27.10.2023 | Lapse of the patent in a contracting state New state(s): MC | published on 29.11.2023 [2023/48] | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045 / JP | [2018/02] | Inventor(s) | 01 /
KARASHIMA, Masatoshi c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1 Muraoka-Higashi 2-chome Fujisawa-shi Kanagawa 251-0012 / JP | 02 /
YAMAMOTO, Katsuhiko c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1 Muraoka-Higashi 2-chome Fujisawa-shi Kanagawa 251-0012 / JP | 03 /
KOJIMA, Takashi c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1 Muraoka-Higashi 2-chome Fujisawa-shi Kanagawa 251-0012 / JP | 04 /
IKEDA, Yukihiro c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 26-1 Muraoka-Higashi 2-chome Fujisawa-shi Kanagawa 251-0012 / JP | [2018/02] | Representative(s) | Held, Stephan Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB Widenmayerstraße 47 80538 München / DE | [2018/02] | Application number, filing date | 16758912.6 | 01.03.2016 | [2018/02] | WO2016JP56236 | Priority number, date | JP20150040647 | 02.03.2015 Original published format: JP 2015040647 | [2018/02] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016140219 | Date: | 09.09.2016 | Language: | JA | [2016/36] | Type: | A1 Application with search report | No.: | EP3266445 | Date: | 10.01.2018 | Language: | EN | [2018/02] | Type: | B1 Patent specification | No.: | EP3266445 | Date: | 11.05.2022 | Language: | EN | [2022/19] | Search report(s) | International search report - published on: | JP | 09.09.2016 | (Supplementary) European search report - dispatched on: | EP | 15.10.2018 | Classification | IPC: | A61K9/10, A61K9/16, A61K31/341, A61K31/405, A61K31/55, A61K47/16, A61K47/18, A61K47/20, A61K47/22, A61K47/32, A61K47/34, A61K47/38, A61K9/14, A61K31/522, A61P7/10, A61P25/08, A61P29/00 | [2021/42] | CPC: |
A61K9/146 (EP,US);
A61K31/341 (US);
A61K31/405 (US);
A61K31/522 (EP,US);
A61K31/55 (US);
A61K47/16 (EP,US);
A61K47/18 (EP,US);
A61K47/20 (EP,US);
A61K47/22 (EP,US);
A61K47/32 (EP,US);
A61K47/34 (EP,US);
A61K47/38 (EP,US);
A61K9/10 (EP,US);
A61K9/145 (EP,US);
A61K9/1617 (EP,US);
A61K9/1623 (EP,US);
A61K9/1652 (EP,US);
A61P25/08 (EP);
|
Former IPC [2018/46] | A61K9/10, A61K9/16, A61K31/341, A61K31/405, A61K31/55, A61K47/16, A61K47/18, A61K47/20, A61K47/22, A61K47/32, A61K47/34, A61K47/38, A61K9/14 | ||
Former IPC [2018/02] | A61K9/10, A61K9/16, A61K31/341, A61K31/405, A61K31/55, A61K47/16, A61K47/18, A61K47/20, A61K47/22, A61K47/32, A61K47/34, A61K47/38 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/02] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | SUSPENSION ODER ZUSAMMENSETZUNG MIT NANOKRISTALL UND HERSTELLUNGSVERFAHREN DAFÜR | [2018/02] | English: | SUSPENSION OR COMPOSITION CONTAINING NANO-COCRYSTAL AND MANUFACTURING METHOD THEREFOR | [2018/02] | French: | SUSPENSION OU COMPOSITION CONTENANT DES NANOCRISTAUX ET SON PROCÉDÉ DE PRODUCTION | [2018/02] | Entry into regional phase | 30.08.2017 | Translation filed | 30.08.2017 | National basic fee paid | 30.08.2017 | Search fee paid | 30.08.2017 | Designation fee(s) paid | 30.08.2017 | Examination fee paid | Examination procedure | 30.08.2017 | Examination requested [2018/02] | 30.08.2017 | Date on which the examining division has become responsible | 07.05.2019 | Amendment by applicant (claims and/or description) | 26.02.2020 | Despatch of a communication from the examining division (Time limit: M04) | 07.07.2020 | Reply to a communication from the examining division | 09.09.2021 | Cancellation of oral proceeding that was planned for 14.09.2021 | 14.09.2021 | Date of oral proceedings (cancelled) | 06.10.2021 | Communication of intention to grant the patent | 16.02.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 16.02.2022 | Fee for grant paid | 16.02.2022 | Fee for publishing/printing paid | 31.03.2022 | Communication of intention to grant the patent | 05.04.2022 | Receipt of the translation of the claim(s) | Opposition(s) | 14.02.2023 | No opposition filed within time limit [2023/16] | Fees paid | Renewal fee | 28.03.2018 | Renewal fee patent year 03 | 29.03.2019 | Renewal fee patent year 04 | 30.03.2020 | Renewal fee patent year 05 | 30.03.2021 | Renewal fee patent year 06 | 23.03.2022 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 11.05.2022 | AT | 11.05.2022 | CZ | 11.05.2022 | DK | 11.05.2022 | EE | 11.05.2022 | ES | 11.05.2022 | FI | 11.05.2022 | HR | 11.05.2022 | LT | 11.05.2022 | LV | 11.05.2022 | MC | 11.05.2022 | NL | 11.05.2022 | PL | 11.05.2022 | RO | 11.05.2022 | RS | 11.05.2022 | SE | 11.05.2022 | SI | 11.05.2022 | SK | 11.05.2022 | SM | 11.05.2022 | BG | 11.08.2022 | NO | 11.08.2022 | GR | 12.08.2022 | IS | 11.09.2022 | PT | 12.09.2022 | [2023/48] |
Former [2023/25] | AL | 11.05.2022 | |
AT | 11.05.2022 | ||
CZ | 11.05.2022 | ||
DK | 11.05.2022 | ||
EE | 11.05.2022 | ||
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
HR | 11.05.2022 | ||
LT | 11.05.2022 | ||
LV | 11.05.2022 | ||
NL | 11.05.2022 | ||
PL | 11.05.2022 | ||
RO | 11.05.2022 | ||
RS | 11.05.2022 | ||
SE | 11.05.2022 | ||
SI | 11.05.2022 | ||
SK | 11.05.2022 | ||
SM | 11.05.2022 | ||
BG | 11.08.2022 | ||
NO | 11.08.2022 | ||
GR | 12.08.2022 | ||
IS | 11.09.2022 | ||
PT | 12.09.2022 | ||
Former [2023/17] | AL | 11.05.2022 | |
AT | 11.05.2022 | ||
CZ | 11.05.2022 | ||
DK | 11.05.2022 | ||
EE | 11.05.2022 | ||
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
HR | 11.05.2022 | ||
LT | 11.05.2022 | ||
LV | 11.05.2022 | ||
NL | 11.05.2022 | ||
PL | 11.05.2022 | ||
RO | 11.05.2022 | ||
RS | 11.05.2022 | ||
SE | 11.05.2022 | ||
SK | 11.05.2022 | ||
SM | 11.05.2022 | ||
BG | 11.08.2022 | ||
NO | 11.08.2022 | ||
GR | 12.08.2022 | ||
IS | 11.09.2022 | ||
PT | 12.09.2022 | ||
Former [2023/09] | AT | 11.05.2022 | |
CZ | 11.05.2022 | ||
DK | 11.05.2022 | ||
EE | 11.05.2022 | ||
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
HR | 11.05.2022 | ||
LT | 11.05.2022 | ||
LV | 11.05.2022 | ||
NL | 11.05.2022 | ||
PL | 11.05.2022 | ||
RO | 11.05.2022 | ||
RS | 11.05.2022 | ||
SE | 11.05.2022 | ||
SK | 11.05.2022 | ||
SM | 11.05.2022 | ||
BG | 11.08.2022 | ||
NO | 11.08.2022 | ||
GR | 12.08.2022 | ||
IS | 11.09.2022 | ||
PT | 12.09.2022 | ||
Former [2023/07] | AT | 11.05.2022 | |
DK | 11.05.2022 | ||
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
HR | 11.05.2022 | ||
LT | 11.05.2022 | ||
LV | 11.05.2022 | ||
NL | 11.05.2022 | ||
PL | 11.05.2022 | ||
RS | 11.05.2022 | ||
SE | 11.05.2022 | ||
BG | 11.08.2022 | ||
NO | 11.08.2022 | ||
GR | 12.08.2022 | ||
IS | 11.09.2022 | ||
PT | 12.09.2022 | ||
Former [2022/51] | AT | 11.05.2022 | |
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
HR | 11.05.2022 | ||
LT | 11.05.2022 | ||
LV | 11.05.2022 | ||
NL | 11.05.2022 | ||
PL | 11.05.2022 | ||
RS | 11.05.2022 | ||
SE | 11.05.2022 | ||
BG | 11.08.2022 | ||
NO | 11.08.2022 | ||
GR | 12.08.2022 | ||
IS | 11.09.2022 | ||
PT | 12.09.2022 | ||
Former [2022/50] | AT | 11.05.2022 | |
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
HR | 11.05.2022 | ||
LT | 11.05.2022 | ||
LV | 11.05.2022 | ||
NL | 11.05.2022 | ||
PL | 11.05.2022 | ||
RS | 11.05.2022 | ||
SE | 11.05.2022 | ||
BG | 11.08.2022 | ||
NO | 11.08.2022 | ||
GR | 12.08.2022 | ||
PT | 12.09.2022 | ||
Former [2022/49] | AT | 11.05.2022 | |
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
HR | 11.05.2022 | ||
LT | 11.05.2022 | ||
LV | 11.05.2022 | ||
NL | 11.05.2022 | ||
SE | 11.05.2022 | ||
BG | 11.08.2022 | ||
NO | 11.08.2022 | ||
GR | 12.08.2022 | ||
PT | 12.09.2022 | ||
Former [2022/48] | AT | 11.05.2022 | |
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
LT | 11.05.2022 | ||
NL | 11.05.2022 | ||
SE | 11.05.2022 | ||
NO | 11.08.2022 | ||
PT | 12.09.2022 | ||
Former [2022/47] | AT | 11.05.2022 | |
ES | 11.05.2022 | ||
FI | 11.05.2022 | ||
LT | 11.05.2022 | ||
SE | 11.05.2022 | ||
NO | 11.08.2022 | ||
PT | 12.09.2022 | Documents cited: | Search | [A]US2010184792 (SOWA CHRISTIAN [DE], et al) [A] 1-13 * paragraph [0001] * * example - *; | [ID]WO2013057169 (UNIV GENT [BE]) [ID] 1-13 * page 1, line 5 - line 13 * * page 3, line 15 - page 4, line 7 * * sentence 7 - sentence 21 * * examples 2,3 * * claims 1-15 *; | [Y] - KESISOGLOU ET AL, "Nanosizing - Oral formulation development and biopharmaceutical evaluation", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM, NL, (20070824), vol. 59, no. 7, doi:10.1016/J.ADDR.2007.05.003, ISSN 0169-409X, pages 631 - 644, XP022211984 [Y] 1,3-7,9-11,13 * the whole document * * abstract * * page 633, column l, line 20 - column r, line 51 * * page 635, column l, line 34 - page 636, column l, line 14 * DOI: http://dx.doi.org/10.1016/j.addr.2007.05.003 | [YDA] - GOUD N RAJESH ET AL, "Novel furosemide cocrystals and selection of high solubility drug forms", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, (20120131), vol. 101, no. 2, doi:10.1002/JPS.22805, ISSN 0022-3549, pages 664 - 680, XP009508307 [YD] 1,3-7,9-11,13 * the whole document * * abstract * * scheme 1 * * page 675, column r, line 1 - page 677, column r, line 21 * [A] 2,8,12 DOI: http://dx.doi.org/10.1002/jps.22805 | International search | [A]JP2008503495 (Transform Pharmaceuticals, Inc.) [A] 1-13 * , claims; examples & US 2007/0299033 A1 & WO 2006/007448 A2 & EP 1765379 A2 *; | [A]JP2008514241 (Cadbury Adams USA L.L.C.) [A] 1-13 * , claims; paragraphs [0025] to [0026]; examples & US 2006/0068059 A1 & WO 2006/039651 A1 & EP 1806980 A1 *; | [A]JP2010538037 (BASF SE) [A] 1-13 * , claims; paragraph [0023]; paragraph [0045], production method VI; example 6 & US 2010/0184792 A1 & WO 2009/047043 A1 & EP 2197278 A1 & KR 10-2010-0061719 A & CN 101795566 A *; | [A]JP2011529101 (University of Bradford) [A] 1-13 * , claims; examples & US 2011/0177136 A1 & WO 2010/013035 A1 & EP 2328665 A1 & CN 102202753 A *; | [A]JP2012501971 (Vertex Pharmaceuticals Inc.) [A] 1-13 * , claims; paragraphs [0014], [0060]; examples & US 2011/0236478 A1 & WO 2010/027921 A1 & EP 2323622 A1 & KR 10-2011-0050549 A & CN 102215816 A *; | [XA]US2012039957 (BRZECZKO ALBERT W [US], et al) [X] 11-13 * , claims; paragraphs [0023] to [0035], [0061]; examples 5, 7 & WO 2012/021819 A1 * [A] 1-10; | [A]JP2012522026 (Tibotec Pharmaceuticals) [A] 1-13 * , claims; examples 3, 4 & US 2012/0028998 A1 & WO 2010/112411 A1 & EP 2413936 A1 & CN 102369009 A *; | [A]WO2013147072 (TAIHO PHARMACEUTICAL CO LTD [JP]) [A] 1-13 * , claims; test example 3 & TW 201400447 A *; | [PA]WO2015093367 (NIPPON SODA CO [JP]) [PA] 1-13* , claims; examples & TW 201526795 A *; | [A] - SANDER,J.R.G. et al., "Pharmaceutical Nano- Cocrystals: Sonochemical Synthesis by Solvent Selection and Use of a Surfactant", Angewandte Chemie International Edition, (20100000), vol. 49, pages 7284 - 7288, XP055477547 [A] 1-13 * , p.7284, p.7287, Experimantal Section * DOI: http://dx.doi.org/10.1002/anie.201002588 |